Type 2 Inflammation and Prurigo Nodularis

This website is intended exclusively for healthcare professionals residing and/or working in Oman.

Type 2 Inflammation and Prurigo Nodularis

MAT-BH-2200596/V1/July 2022

YOU WILL NOW BE LEAVING THE SITE

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in Oman.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.